For older adults with diabetes, there is no evidence to suggest that the incidence of dementia differs for those using GLP-1 RAs vs DPP4is.

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related ...

India accounts for 1 in 7 adults living with diabetes globally. An estimated 89.8 million adults aged 20-79 years in India ...

Discover the critical connection between diabetes and heart disease, learn how to manage risks, and find out what preventive ...

"Dentist here. STOP SMOKING. Smoking leads to bad oral health and mouth cancers. Bad oral health can lead to blood infections ...

This new article publication from Acta Pharmaceutica Sinica B, discusses how melatonin receptor 1a alleviates sleep ...

C, the 'bad cholesterol', is a crucial factor in heart disease. Learn from experts how reducing LDL-C can save lives, ...

Discover a study highlighting the high prevalence of MASLD and liver fibrosis in patients with type 2 diabetes using ...

Discontinuation of GLP-1 receptor agonists suggested before conception rather than between start of pregnancy and end of first trimester.

Recently, the team led by Chief Physician Quan Zhang and Associate Professor Feng Liu at Tianjin Medical University General Hospital systematically ...

SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.